Save Page settings
IBM MarketScan Inpatient View and Outpatient View
Maximize patient reported outcomes with ePRO

Our ePRO technology is integrated directly into IBM Clinical Development EDC allowing for seamless deployment and data integrity.
Transformational healthcare solutions from Truven Health Analytics®, now offered by IBM Watson Health.
Resource Type
Introducing our new ePRO Mobile App: My Clinical Diary

We're excited to announce the launch of My Clinical Diary, a new mobile app that lets study participants log their data from any IOS and android-enabled smartphone with web access. Take a personalized demo today and experience the future of clinical trials.
Request a demo
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Resource Type
Our ePRO Mobile App:
My Clinical Diary
My Clinical Diary is our ePRO mobile app that lets clinical study participants log their data from any desktop or iOS/ Android-enabled device. This advanced ePRO solution ensures that a patient-centric experience is at the heart of your clinical trial.
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
Watch the video
Resource Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
Watch the video
Patient Engagement | ePRO
Put the patient at the center of your trial
Put the patient at the center of your trial
Patient participation and maximized capture of ePROs are essential to clinical study success and lead to improvements in patient-clinician communication, patient satisfaction, symptom management and control, and quality of life.

Our ePRO technology replaces conventional reporting methods and allows patients to share important information with caregivers at any time. 
Learn more
Designed to put the patient at the center of your trial
Vadem te ad mortem tyranno dabis pro amico
• Quicker access to primary efficacy data from each patient's perspective

• Validation of all data even in multilingual global studies - through a single database

• More Informed decision making through the evaluation of on-demand source data

• Easy deployment of mid-study changes to keep studies on track and on budget

• Increased efficiency by elimination double data entry and the need to decipher illegible handwriting you find
• Support for quality of life (SF 12 and SF 36) and many other new templates
Request a demo
Heading copy iubet igitur
Vadem te ad mortem tyranno dabis pro amico
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Patient-Centric
Electronic patient-reported outcomes (ePRO) via mobile devices or web entry, is designed to support and empower patients with visual impairment or other disabilities that could affect data entry and compliance.
CTA Label
Securely-Integrated
Direct integration with IBM Clinical Development (EDC) ecosystem allows for security rich features that instills confidence in your patients' data.
CTA Label
Adaptable
Single questionnaire allows study designers flexible options for their patients. With 30 languages supported, this solution affords researchers the flexibility to conduct their studies with different patient populations regardless of language.
CTA Label
What is ePRO?
An electronic patient-reported outcome (ePRO) is a patient-reported outcome that is collected by electronic methods. ePRO methods are most commonly used in clinical trials, but they are also used elsewhere in healthcare.
Learn more
Every therapeutic area
Supports trials in every therapeutic area, including:

• Gastroenterology • Urology
• Respiratory
• Cardiology • Women's Health
• Rheumatology
• Oncology • Endocrinology
• Infectious Disease
• Pediatric
• Metabolic
• Musculoskeletal
• Psychiatry/CNS • Immunology
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Heading copy iubet igitur
Body copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Title
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Card Type
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos
CTA Label
Interactive demo
Estimate top-line market demand for your drug or device and understand payer and practice trends that may affect market performance.

Please fill out the form to launch our interactive inpatient or outpatient view demo.
Event details title
calendar January 1, 2010
time 10:00 AM - 11:00 AM PST
person John Doe
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
Quote copy quod si ita sit, cur opera philosophiae sit danda nescio. Vadem te ad mortem tyranno dabis pro amico, ut Pythagoreus ille Siculo fecit tyranno.
John Doe,
ille Siculo fecit
1. This promotional offer gives eligible customers the opportunity to order access to the IBM Clinical Development Electronic Reported Outcomes (ePRO) module for one study without being charged for the associated on-demand set-up charge or charged for the first 10,000 questionnaires (e.g., the Tier 1: 1 to 10,000 ePRO Case Report Forms) apart of the study.  This offer only applies to eligible customers, which are customers who have never ordered ePRO and ordering ePRO for the first-time because of this offer.  This offer expires on the 3 year anniversary of the study using the ePRO module, and thereafter, the rates specified on the Transaction Document shall apply.  Except for the waived charges specified herein, all other mandatory usage charges shall apply for usage of ePRO.
APOLLO NOSCERE NOSMET
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
CTA Label
Heading copy iubet igitur nos Pythius Apollo noscere nosmet ipsos danda nescio
CTA Label
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.
Utram tandem linguam nescio? Igitur ne dolorem quidem. Nemo igitur esse beatus potest. Facillimum id quidem est, inquam. Bonum patria: miserum exilium. Iam contemni non poteris.